- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1459
1,459 companies
Lowell Farms
Market Cap: CA$726.0k
Engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California.
LOWL
CA$0.03
7D
-25.0%
1Y
-81.8%
Telesis Bio
Market Cap: US$506.1k
A synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.
TBIO
US$0.28
7D
-3.4%
1Y
-96.6%
Sangui Biotech International
Market Cap: €419.8k
Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.
SBH
€0.002
7D
0%
1Y
-77.8%
LungLife AI
Market Cap: UK£275.9k
A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.
LLAI
UK£0.009
7D
-18.2%
1Y
-96.9%
Altamira Therapeutics
Market Cap: US$326.3k
Operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia.
CYTO.F
US$0.07
7D
-12.5%
1Y
-96.7%
TheraVet
Market Cap: €292.7k
A veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States.
ALVET
€0.082
7D
0%
1Y
-90.8%
Many Bright Ideas Technologies
Market Cap: CA$345.2k
Does not have significant operations.
MBI.H
CA$0.02
7D
0%
1Y
-78.9%
Scandion Oncology
Market Cap: SEK 2.2m
A clinical-stage biotechnology company, develops medicines for the treatment of cancer.
SCOL
SEK 0.0094
7D
4.4%
1Y
-99.6%
TC Biopharm (Holdings)
Market Cap: US$123.1k
A clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform.
TCBP.Y
US$0.30
7D
15.4%
1Y
-99.9%
Cannonau
Market Cap: US$72.5k
Provides cannabidiol based products.
CNNC
US$0.0003
7D
0%
1Y
-97.3%
Vaxxinity
Market Cap: US$25.3k
A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.
VAXX
US$0.05
7D
42.9%
1Y
-92.5%
Lucy Scientific Discovery
Market Cap: US$8.8k
An early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products.
LSDI.F
US$0.0002
7D
-96.0%
1Y
-100.0%
Gritstone bio
Market Cap: US$1.5k
A clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases.
GRTS.Q
US$0.000001
7D
0%
1Y
-100.0%
Molecular Templates
Market Cap: US$1.3k
A clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States.
MTEM
US$0.0001
7D
9,900.0%
1Y
-100.0%
eFFECTOR Therapeutics
Market Cap: US$940.0
A biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer.
EFTR
US$0.0002
7D
0%
1Y
-100.0%
Ampio Pharmaceuticals
Market Cap: US$681.0
A biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.
AMPE
US$0.0006
7D
0%
1Y
-99.9%
Clever Leaves Holdings
Market Cap: US$350.0
Operates in the botanical cannabinoid and nutraceutical industries.
CLVR
US$0.0002
7D
0%
1Y
-100.0%
NexImmune
Market Cap: US$139.0
A clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States.
NEXI
US$0.0001
7D
0%
1Y
-100.0%
DermTech
Market Cap: US$35.0
A molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States.
DMTK.Q
US$0.00001
7D
900.0%
1Y
-100.0%